Publication

Byline

Paos Industries to declare Quarterly Results

Mumbai, Oct. 30 -- Paos Industries will hold a meeting of the Board of Directors of the Company on 5 November 2026. Published by HT Digital Content Services with permission from Capital Market.... और पढ़ें


Odisha clears Rs 3,855 crore investment proposals for 22 projects, 7,765 jobs expected

Bhubaneswar, Oct. 30 -- Odisha on Thursday approved investment proposals worth Rs 3,855 crore for 22 industrial projects, which are expected to create 7,765 employment opportunities across the state. ... और पढ़ें


$6.3 Billion Binance Hack Shocks Crypto Markets

India, Oct. 30 -- Cryptocurrencies plunged heavily during the past 24 hours as markets digested the scale and scope of the largest crypto hack ever. In a daring heist that lasted only about 20 minutes... और पढ़ें


Cyclone Arnab aftermath: Swollen Rushikulya river floods several areas in Ganjam, villages submerged

Bhubaneswar, Oct. 30 -- Severe flooding has disrupted normal life across Odisha's Ganjam district after the Rushikulya River swelled. The swollen river reportedly caused widespread damage. Several vil... और पढ़ें


BSE SME Core4 Engineers makes a tepid market debut

Mumbai, Oct. 30 -- The scrip was listed at Rs 74.40, a 20% discount to the IPO price. The stock is currently frozen at its upper limit of 5% over its listing price. The counter hit a high of Rs 78.12... और पढ़ें


Hyundai Bayon on road price : హైదరాబాద్​లో హ్యుందాయ్ బేయాన్ ఆన్​రోడ్​ ప్రైజ్​ వివరాలు ఇలా..

భారతదేశం, అక్టోబర్ 30 -- దిగ్గజ ఆటోమొబైల్​ సంస్థ హ్యుందాయ్.. కొత్త ఎస్​యూవీని ఇటీవలే భారత మార్కెట్​లో లాంచ్ చేసిన విషయం తెలిసిందే. దాని పేరు హ్యుందాయ్ బేయాన్. ఈ ఎస్​యూవీ రూ. 9.9లక్షల ప్రారంభ ఎక్స్​షోర... और पढ़ें


Euro regains momentum amid dollar pullback; Hawkish pause from ECB

Mumbai, Oct. 30 -- Euro regained some momentum on Friday as dollar edged lower in line with decline US treasury yields. DXY is holding at around 101.66, down 0.24% on the day. Meanwhile, the ECB yeste... और पढ़ें


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... और पढ़ें


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... और पढ़ें